APWM
GSK icon

Atlas Private Wealth Management’s GSK GSK Stock Holding History

Atlas Private Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-458
Closed -$22K – 389
2020
Q3 		$22K Hold
458
– – 0.02% 243
2020
Q2 		$23K Hold
458
– – 0.02% 258
2020
Q1 		$22K Hold
458
– – 0.02% 241
2019
Q4 		$27K Buy
+458
New +$25.5K 0.02% 255

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Atlas Private Wealth Management's GSK Position: Q4 2020 in Review

Atlas Private Wealth Management sold out of GSK (GSK) in Q4 2020, closing a stake of 458 shares — an estimated $22K sold.

Atlas Private Wealth Management first reported a position in GSK in Q4 2019 and held it in 4 quarters. The position peaked at $27K in Q4 2019. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

  • Atlas Private Wealth Management reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
  • Atlas Private Wealth Management sold 458 GSK shares in Q4 2020, an estimated $22K.
  • Atlas Private Wealth Management first reported a position in GSK in Q4 2019 and held it in 4 quarters.
  • Atlas Private Wealth Management's GSK position peaked at $27K in Q4 2019.
  • 818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Atlas Private Wealth Management's 13F filing for Q4 2020, filed 27 Jan 2021.